Patents by Inventor Adam J. Morgan

Adam J. Morgan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DEUTERATED DERIVATIVES OF RUXOLITINIB
    Publication number: 20170239254
    Abstract: The present invention in one embodiment provides a compound of Formula A: or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising the compound; and methods of treating the indications disclosed herein.
    Type: Application
    Filed: March 9, 2017
    Publication date: August 24, 2017
    Inventors: I. Robert Silverman, Julie F. Liu, Adam J. Morgan, Bhaumik Pandya, Scott L. Harbeson
  • DEUTERATED CFTR POTENTIATORS
    Publication number: 20170137383
    Abstract: This invention relates to compounds of Formula I: and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering a CFTR potentiator.
    Type: Application
    Filed: November 22, 2016
    Publication date: May 18, 2017
    Inventor: Adam J. Morgan
  • DEUTERATED IBRUTINIB
    Publication number: 20170015670
    Abstract: The present invention in one embodiment provides a compound of Formula I: or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formula I are as defined in the specification.
    Type: Application
    Filed: July 27, 2016
    Publication date: January 19, 2017
    Inventors: Roger D. Tung, Adam J. Morgan
  • Deuterated CFTR potentiators
    Patent number: 9512079
    Abstract: This invention relates to compounds of Formula I: and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering a CFTR potentiator.
    Type: Grant
    Filed: October 23, 2015
    Date of Patent: December 6, 2016
    Assignee: Concert Pharmaceuticals, Inc.
    Inventor: Adam J. Morgan
  • 4-HYDROXYBUTYRIC ACID ANALOGS
    Publication number: 20160326086
    Abstract: This invention relates to novel derivatives of 4-hydroxybutyric acid and prodrugs thereof, and pharmaceutically acceptable salts of the foregoing. This invention also provides pharmaceutical compositions comprising a compound of this invention and the use of such compositions in methods of treating narcolepsy, fibromyalgia, other disorders or conditions that are beneficially treated by improving nocturnal sleep or by administering sodium oxybate.
    Type: Application
    Filed: April 11, 2016
    Publication date: November 10, 2016
    Inventors: Roger D. Tung, Adam J. Morgan, I. Robert Silverman
  • Deuterated ibrutinib
    Patent number: 9422295
    Abstract: The present invention in one embodiment provides a compound of Formula (I); or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formula (I) are as defined in the specification.
    Type: Grant
    Filed: July 30, 2013
    Date of Patent: August 23, 2016
    Assignee: CONCERT PHARMACEUTICALS, INC.
    Inventors: Roger D. Tung, Adam J. Morgan
  • 4-hydroxybutyric acid analogs
    Patent number: 9309182
    Abstract: This invention relates to novel derivatives of 4-hydroxybutyric acid and prodrugs thereof, and pharmaceutically acceptable salts of the foregoing. This invention also provides pharmaceutical compositions comprising a compound of this invention and the use of such compositions in methods of treating narcolepsy, fibromyalgia, other disorders or conditions that are beneficially treated by improving nocturnal sleep or by administering sodium oxybate.
    Type: Grant
    Filed: April 17, 2014
    Date of Patent: April 12, 2016
    Assignee: Concert Pharmaceuticals, Inc.
    Inventors: Roger D. Tung, Adam J. Morgan
  • DEUTERATED CFTR POTENTIATORS
    Publication number: 20160039764
    Abstract: This invention relates to compounds of Formula I: and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering a CFTR potentiator.
    Type: Application
    Filed: October 23, 2015
    Publication date: February 11, 2016
    Inventor: Adam J. Morgan
  • Deuterated derivatives of ruxolitinib
    Patent number: 9249149
    Abstract: The present invention in one embodiment provides a compound of Formula A: or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising the compound; and methods of treating the indications disclosed herein.
    Type: Grant
    Filed: May 8, 2015
    Date of Patent: February 2, 2016
    Assignee: Concert Pharmaceuticals, Inc.
    Inventors: I. Robert Silverman, Julie F. Liu, Adam J. Morgan, Bhaumik Pandya, Scott L. Harbeson
  • DEUTERATED PALBOCICLIB
    Publication number: 20160024084
    Abstract: This invention relates to novel pyrido[2,3-d]pyrimidinones and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering a CDK-4 and/or CDK-6 inhibitor.
    Type: Application
    Filed: March 12, 2014
    Publication date: January 28, 2016
    Inventor: Adam J. Morgan
  • Deuterated CFTR potentiators
    Patent number: 9181192
    Abstract: This invention relates to compounds of Formula I: and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering a CFTR potentiator.
    Type: Grant
    Filed: September 19, 2014
    Date of Patent: November 10, 2015
    Assignee: Concert Pharmaceuticals, Inc.
    Inventor: Adam J. Morgan
  • Deuterated Derivatives of Ruxolitinib
    Publication number: 20150239896
    Abstract: The present invention in one embodiment provides a compound of Formula A: or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising the compound; and methods of treating the indications disclosed herein.
    Type: Application
    Filed: May 8, 2015
    Publication date: August 27, 2015
    Inventors: I. Robert Silverman, Julie F. Liu, Adam J. Morgan, Bhaumik Pandya, Scott L. Harbeson
  • Deuterated Ibrutinib
    Publication number: 20150210699
    Abstract: The present invention in one embodiment provides a compound of Formula (I); or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formula (I) are as defined in the specification.
    Type: Application
    Filed: July 30, 2013
    Publication date: July 30, 2015
    Applicant: Concert Pharmaceuticals, Inc.
    Inventors: Roger D. Tung, Adam J. Morgan
  • DEUTERATED DERIVATIVES OF RUXOLITINIB
    Publication number: 20150197525
    Abstract: The present invention in one embodiment provides a compound of Formula A: or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising the compound; and methods of treating the indications disclosed herein.
    Type: Application
    Filed: December 15, 2014
    Publication date: July 16, 2015
    Inventors: I. Robert Silverman, Julie F. Liu, Adam J. Morgan, Bhaumik Pandya, Scott L. Harbeson
  • DEUTERATED CFTR POTENTIATORS
    Publication number: 20150099780
    Abstract: This invention relates to compounds of Formula I: and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering a CFTR potentiator.
    Type: Application
    Filed: September 19, 2014
    Publication date: April 9, 2015
    Inventor: Adam J. Morgan
  • 4-HYDROXYBUTYRIC ACID ANALOGS
    Publication number: 20140343119
    Abstract: This invention relates to novel derivatives of 4-hydroxybutyric acid and prodrugs thereof, and pharmaceutically acceptable salts of the foregoing. This invention also provides pharmaceutical compositions comprising a compound of this invention and the use of such compositions in methods of treating narcolepsy, fibromyalgia, other disorders or conditions that are beneficially treated by improving nocturnal sleep or by administering sodium oxybate.
    Type: Application
    Filed: April 17, 2014
    Publication date: November 20, 2014
    Applicant: Concert Pharmaceuticals, Inc.
    Inventors: Roger D. Tung, Adam J. Morgan, I. Robert Silverman
  • Deuterated CFTR potentiators
    Patent number: 8865902
    Abstract: This invention relates to compounds of Formula I: and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering a CFTR potentiator.
    Type: Grant
    Filed: November 18, 2013
    Date of Patent: October 21, 2014
    Assignee: Concert Pharmaceuticals, Inc.
    Inventor: Adam J. Morgan
  • 4-hydroxybutyric acid analogs
    Patent number: 8759394
    Abstract: This invention relates to novel derivatives of 4-hydroxybutyric acid and prodrugs thereof, and pharmaceutically acceptable salts of the foregoing. This invention also provides pharmaceutical compositions comprising a compound of this invention and the use of such compositions in methods of treating narcolepsy, fibromyalgia, other disorders or conditions that are beneficially treated by improving nocturnal sleep or by administering sodium oxybate.
    Type: Grant
    Filed: February 14, 2012
    Date of Patent: June 24, 2014
    Assignee: Concert Pharmaceuticals, Inc.
    Inventors: Roger D. Tung, Adam J. Morgan
  • DEUTERATED CFTR POTENTIATORS
    Publication number: 20140073667
    Abstract: This invention relates to compounds of Formula I: and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering a CFTR potentiator.
    Type: Application
    Filed: November 18, 2013
    Publication date: March 13, 2014
    Inventor: Adam J. Morgan
  • System and method for sealing battery separator
    Patent number: 8551642
    Abstract: One embodiment of the present subject matter includes a battery having a stack of substantially planar battery electrodes, the stack including a first electrode including a first tab, and a second electrode including a second tab, with the first tab electrically connected to the second tab. The embodiment includes a first separator layer and a second separator layer sandwiching the first electrode, with the edges of the first separator layer and the second separator connected with a weld, the first separator layer and the second separator layer defining an interior space in which the first electrode is disposed, with the first tab extending outside the interior space. The embodiment includes a battery housing having electrolyte disposed therein, the housing including at least a first aperture and a feedthrough aperture; a lid conformed and sealed to the first aperture; and a feedthrough conformed and sealed to the feedthrough aperture.
    Type: Grant
    Filed: March 1, 2011
    Date of Patent: October 8, 2013
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Adam J. Morgan, Ignacio Chi, Brian L. Schmidt, Benjamin J. Haasl, Jon Schell